These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 8821056

  • 1. Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
    Kupsch A, Oertel WH, Earl CD, Sautter J.
    J Neural Transm Suppl; 1995; 46():193-207. PubMed ID: 8821056
    [Abstract] [Full Text] [Related]

  • 2. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)].
    Mínguez-Castellanos A, Escamilla-Sevilla F.
    Rev Neurol; 1995; 41(10):604-14. PubMed ID: 16288424
    [Abstract] [Full Text] [Related]

  • 3. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM, Altar CA, Cedarbaum JM, Hyman C, Wiegand SJ.
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line.
    Meyer M, Johansen J, Gramsbergen JB, Johansen TE, Zimmer J.
    Exp Neurol; 2000 Jul; 164(1):82-93. PubMed ID: 10877918
    [Abstract] [Full Text] [Related]

  • 6. Emerging restorative treatments for Parkinson's disease.
    Deierborg T, Soulet D, Roybon L, Hall V, Brundin P.
    Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacologically active microcarriers releasing glial cell line - derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats.
    Tatard VM, Sindji L, Branton JG, Aubert-Pouëssel A, Colleau J, Benoit JP, Montero-Menei CN.
    Biomaterials; 2007 Apr; 28(11):1978-88. PubMed ID: 17240442
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539
    [Abstract] [Full Text] [Related]

  • 13. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
    Sautter J, Tseng JL, Braguglia D, Aebischer P, Spenger C, Seiler RW, Widmer HR, Zurn AD.
    Exp Neurol; 1998 Jan 24; 149(1):230-6. PubMed ID: 9454632
    [Abstract] [Full Text] [Related]

  • 14. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM.
    Exp Neurol; 1998 Oct 24; 153(2):195-202. PubMed ID: 9784279
    [Abstract] [Full Text] [Related]

  • 15. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR.
    Brain Res; 2009 Jun 18; 1276():39-49. PubMed ID: 19389387
    [Abstract] [Full Text] [Related]

  • 16. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
    Törnqvist N, Björklund L, Strömberg I.
    Exp Neurol; 2001 Jun 18; 169(2):329-39. PubMed ID: 11358446
    [Abstract] [Full Text] [Related]

  • 17. Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application.
    Yasuhara T, Date I.
    Cell Transplant; 2007 Jun 18; 16(2):125-32. PubMed ID: 17474294
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC.
    Gene Ther; 1999 Dec 18; 6(12):1936-51. PubMed ID: 10637445
    [Abstract] [Full Text] [Related]

  • 19. A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease.
    Lapchak PA.
    Mov Disord; 1998 Dec 18; 13 Suppl 1():49-54. PubMed ID: 9613719
    [Abstract] [Full Text] [Related]

  • 20. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease.
    Lapchak PA, Gash DM, Jiao S, Miller PJ, Hilt D.
    Exp Neurol; 1997 Mar 18; 144(1):29-34. PubMed ID: 9126148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.